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PURPOSE: The clinical significance and prognostic value of 
the histopathologic parameters used in both the Dukes and 
Jass classifications were evaluated to select those with an 
independent effect on survival after radical surgery for colt- 
rectal cancer. METHODS: The depth of local spread (limited 
to the bowel wall or extended beyond it), the number of 
metastatic lymph nodes (none, 1-4, more than 4), the 
character of the invasive margin (pushing or infiltrating), 
and the presence or absence of conspicuous peritumoral 
lymphocytic infiltration were assessed in 235 patients who 
had undergone radical resection for colorectal cancer. The 
influence of these variables on survival was studied by 
tlnivariate and multivariate analysis. RESULTS: No signifi- 
cant difference in survival was found between patients with 
conspicuous peritumoral infiltrate and those without it; 
moreover, multivariate analysis failed to show any indepen- 
dent prognostic value for either lymphocytic infiltration or 
depth of local invasion. However, the character of the 
invasive margin and the number of metastatic lymph nodes 
were identified as the only variables with any independent 
importance on survival. Based on these data, a new prog- 
nostic model may be proposed; it uses the character of the 
infiltrative margin as a discriminating factor among patients 
within the lymph node-negative (Dukes A and B stages) and 
lymph node-positive (Dukes C1 and C2 subsets) groups. A 
good prognosis for Dukes A, B, and C1 patients was asso- 
ciated with pushing tumors; C1 and C2 patients with infil- 
trating tumors had a poor prognosis. On the whole, the new 
prognostic model has allowed for the placement of 59.6 
percent of our patients into groups that provide a confident 
prognosis. The clinical outcome of Dukes A and B patients 
with infiltrating tumors is still uncertain. CONCLUSIONS: 
The character of the invasive margin is an important prog- 
nostic factor in colorectal cancer. The association of this 
parameter with the traditional Dukes classification may pro- 
vide additional useful prognostic information and aid in the 
selection of those patients who could most benefit from 
adjuvant herapy. [Key words: Colorectal cancer; Dukes 
staging; Jass system; Prognosis] 
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T he Dukes classification, including recent modifi- cations 1, 2 is still widely used in the prognostic 
evaluation of  patients operated on for colorectal can- 
cer, because of its simplicity and good  relationship 
with survival. Nevertheless, the most important weak- 
ness of this classification is the small number  of pa- 
tients who can be included in well-predicted prog- 
nostic groups. Jass and coworkers 3 developed a new 
classification for rectal cancer (also commonly  used 
for colonic cancer) that allows for identification of  a 
larger number  of patients within groups and that pro- 
vides a confident prediction of clinical outcome. 
However,  many doubts have recently been raised 
concerning the reproducibility of  one of the Jass 
pathologic components,  the degree of peritumoral 
lymphocytic infiltration as expressed by the distinc- 
tion between a "conspicuous" and a "less conspicu- 
ous" infiltrate. Because this distinction primarily, de- 
pends on the pathologist's interpretation, this 
parameter remains potentially subjective. 
The aim of this study was to evaluate the clinical 
significance and prognostic value of the histopatho- 
logic parameters used in both the Dukes and Jass 
classifications. Furthermore, those parameters with an 
independent effect on survival were clearly identified 
so the largest number  of  patients possible could be 
placed in well-defined groups with either good or 
poor  prognoses. 
MATERIALS  AND METHODS 
Between 1987 and 1993, 306 patients seen at our 
Operative Unit were histologically diagnosed as hav- 
ing colorectal adenocarcinoma. Two hundred thirty- 
five subjects, 145 males (61.7 percent), with a median 
age of 66 (range, 36-88) years, underwent  radical 
surgical resection by one surgeon (CC). A retrospec- 
tive study was performed on the clinical outcome of 
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these patients. One hundred thirty-one patients (55.7 
percent) had neoplasms of the colon; 104 (44.3 per- 
cent) had neoplasms of the rectum. Operations were 
defined as radical when there was no evidence of 
distant metastases or incomplete clearance of tumor. 
No adjuvant herapeutic protocols were performed. 
Average duration of follow-up for surviving patients 
was 53.4 (range, 25-108) months. Patients who had 
died within 30 days of surgery were excluded from 
the study. 
For each colorectal tumor specimen, the following 
histopathologic variables were assessed by the same 
pathologist (LM): depth of direct spread (limited to 
the bowel wall or extended beyond it); number of 
positive lymph nodes (none, 1-4, more than 4); char- 
acter of the invasive margin (pushing or infiltrating), 
and the presence or absence of conspicuous peritu- 
moral lymphocytic infiltration. The last two parame- 
ters were assessed according to criteria as defined by 
Jass et al, 4 In particular, the character of the invasive 
margin was classified as pushing when advancement 
of the tumor was clearly evident and the tumor had 
pushed the surrounding tissues, thus creating a well- 
delineated border. It was defined as infiltrating when 
the cancer cell spread in the surrounding tissues had 
no distinct border. 
The relationship of these variables with survival 
was analyzed using the Kaplan-Meier survival meth- 
od. 5 Cox model analysis, 6 in a stepwise regression, 
was used to identify those factors that influenced 
survival independently. 
All patients were staged according to Dukes classi- 
fication as modified by the Gastrointestinal Tumor 
Study Group 7 as follows: Stage A, tumors confined to 
the bowel wall; Stage B, tumors extending beyond the 
wall and lymph nodes negative; Stage C1, invasion of 
one to four lymph nodes by the tumor, irrespective of 
extent of local spread; Stage C2, more than four 
lymph nodes involved by tumor, irrespective of ex- 
tent of local spread. This classification took into con- 
sideration the prognostic importance of the subdivi- 
sion of Dukes Class C, which is based on the number 
of positive lymph nodes. 3' 8, 9 We also classified our 
patients according to the prognostic scoring system as 
proposed byJass et al., 3 which is based on the results 
of four histopathologic variables that we had exam- 
ined. Each of the four variables was given an arbitrary 
score, which could add up to a maximum of five. The 
total score was then assigned to a prognostic group 
(Table 1). The relationship between the Dukes and 
Jass groups and survival was estimated using the 
Table 1. 
Jass Scoring Prognostic System 
Variable Score 
Depth of direct spread 
Limited to the bowel wall 0 
Beyond the bowel wall 1 
















Kaplan-Meier method. All survival curves were com- 
pared using the Cox-Mantel text. 
RESULTS 
Clinical and pathologic data relating to the 235 
patients are summarized in Table 2. When all 235 
patients were considered, the five-year survival rate 
was 63.1 percent. Forty-four patients (18.7 percent) 
had Stage A, 116 (49.4 percent) had Stage B, 58 (24.7 
percent) had Stage C1, and 17 (7.2 percent) had Stage 
C2. The five-year survival rates were 87.4 percent for 
patients with Stage A, 70 percent with Stage B, 48 
percent with Stage C1, and 0 percent with Stage C2 
(P < 0.0001; Fig. 1). Using the Jass classification, 3 51 
patients (21.7 percent) fell into Group I, 55 (23.5 
percent) into Group II, 80 (34 percent) into Group III, 
and 49 (20.8 percent) into Group IV. Five-year sur- 
vival rates were 91.6, 71.7, 67.8, and 22.1 percent (P < 
0,0001) for each group, respectively (Fig. 2). 
In evaluating survival with respect o the type of 
invasive margin, 76 patients (32.4 percent) with push- 
ing tumors had an 89 percent five-year survival rate, 
whereas 159 patients (67.6 percent) with infiltrating 
tumors had a 50.4 percent five-year survival rate (P < 
0.0001; Fig. 3). The five-year survival rate of the 160 
patients (68.1 percent) with no metastatic lymph 
nodes was 75.3 percent, whereas the survival rates of 
patients with one to four metastatic lymph nodes and 
those with more than four were the same as those 
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Table 2. 





Male 145 61.7 
Female 90 38.3 
Tumor site 
Colon 131 55.7 
Rectum 104 44.3 
Direct spread 
Within the wall 55 23.4 
Beyond the wall 180 76.6 
Positive lymph nodes 
None 160 68.1 
1-4 58 24.7 
>4 17 7.2 
Lymphocytic infiltration 
Present 45 19.2 
Absent 190 80.8 
Type of invasive margin 
Pushing 76 32.4 
Infiltrating 159 67.6 
Dukes stage 
A 44 18.7 
B 116 49.4 
C1 58 24.7 
C2 17 7.2 
Jass stage 
I 51 21.7 
II 55 23.5 
III 80 34.0 
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Figure 1. Survival of 235 patients with colorectal cancer 
according to Dukes stage. 
who had been classified as C1 and C2, respectively 
(P < 0.0001). With regard to direct spread, the five- 
year survival rate of the 55 patients (23.4 percent) 
with tumors confined to the bowel wall was 83.2 
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Figure 2. Survival of 235 patients with colorectal cancer 

















1 I~-1  
I 
I I I I I I 
20 40 60 80 100 120 
Months  
Figure 3. Survival of 235 patients with colorectal cancer 
according to type of invasive margin. 
percent, whereas the five-year survival rate of the 180 
patients (76.6 percent) with tumors that had extended 
beyond the wall was 56.2 percent (P < 0.001). When 
the absence or presence of conspicuous peritumoral 
lymphocytic infiltration was considered, the differ- 
ence in survival was not statistically significant. In 
fact, the 45 patients (19.2 percent) with conspicuous 
infiltration had a 74.3 percent five-year survival rate, 
whereas the 190 patients (80.8 percen0 without it had 
a 61.4 percent five-year survival rate (P = 0.15). 
By using Cox regression analysis, two of the four 
variables analyzed were selected as having an inde- 
pendent influence on survival--the character of the 
invasive margin and the number of lymph nodes 
invaded by the tumor. The depth of local spread and 
lymphocytic infiltration had no additional influence 
on survival when the selected variables were taken 
into consideration (Table 3). 
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Based on these data, the type of invasive margin as 
a discriminating variable among lymph node-negative 
(Dukes A and B stages) and lymph node-positive 
(Dukes C1 and C2 stages) patients was hypothesized. 
In the former group, 65 patients (27.7 percent) had 
tumors with a pushing margin, and 95 patients (40.4 
percent) had tumors with an infiltrating one. Five-year 
survival rates were 88.5 and 66.1 percent for each 
subset, respectively (P < 0.01; Fig. 4). Among those 
patients with one to four positive lymph nodes, 11 
patients (4.7 percent) had pushing tumors and 47 
(20.0 percent) had infiltrating ones. Five-year survival 
rates were 100 and 28.7 percent for the two subsets, 
respectively (P < 0.001; Fig. 5). The 17 patients (7.2 
percent) with more than four positive lymph nodes 
had tumors that showed an infiltrating margin; their 
five-year survival rate was 0 percent. 
D ISCUSSION 
Although survival after radical surgery for colorec- 
tal carcinoma is quite satisfactory in comparison with 
other types of cancer of the digestive tract, improve- 
ment in survival rates by means of adjuvant therapeu- 
tic protocols is an on-going task. Rational use of 
radiotherapy and chemotherapy requires careful pa- 
tient selection. In fact, only those patients who would 
die, even after having radical resection of the tumor, 
might receive the most benefit from such types of 
therapy. Since 1932, the Dukes classification has cer- 
tainly been the most widely used prognostic tool in 
evaluation of these patients. This has been mainly the 
result of its simplicity in clinical use and its good 
relationship to survival. Among the modifications suc- 
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Figure 4. Survival of Dukes A and B patients according to 
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Figure 5. Survival of Dukes C1 patients according to type 
of invasive margin. 
of the Dukes system, only the subdivision of Dukes C 
lesions into "CI" and "C2" subsets on the basis of the 
level of the positive lymph nodes 2' 10 or their num- 
ber 7-9 has contributed any new significant prognostic 
data. 
Our results are consistent with previous re- 
ports,8, 11-13 which confirm the strong relationship 
between Dukes staging and survival. Nevertheless, 
the most important drawback in the Dukes system is 
the identification of only 15 to 20 percent of patients 
in Stage A with a good prognosis and less than 10 
percent of those in Stage C2 with a poor prognosis. In 
fact, our series showed an 18.7 and 7.2 percent rate, 
respectively. To overcome this limitation, Jass and 
coworkers 3 introduced a new classification based on 
four pathologic variables: local spread, number of 
lymph nodes invaded by tumor, character of the in- 
vasive margin, and peritumoral lymphocytic infiltra- 
tion. These had been selected by means of Cox re- 
gression analysis as having independent prognostic 
value and given weighted scores to identify four prog- 
nostic groups. In our series, the Jass groups were 
significantly related to the survival rate, even if the 
difference in survival between Group lI and Group 
III, which accounted for the majority of our patients, 
was not significant. These data are consistent with 
those in a previous study by Secco et  al.  14 Group I, 
which was characterized by an excellent prognosis, 
and Group IV, which was characterized by a poor 
prognosis, accounted for 21.7 and 20.8 percent of our 
patients, respectively. Therefore, the Jass classifica- 
tion may be considered superior to Dukes staging 
based on the fact that twice as many patients can be 
placed into definite groups with a confident progno-  
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Table 3. 
Multivariate Analysis (Cox Regression Model) of the Four Parameters Used in the Dukes and Jass Classifications 
Variable Categories HR 95% CB P Value 





1-4 2.066 1.220-3.498 
>4 3.713 1.780-7.745 <0.001 
Pushing 1.000 
Infiltrating 4.077 1.790-9,284 0.001 
Present 1.000 
Absent 0.717 0.365-1.409 0.334 
Within the wall 1.000 
Beyond the wall 1.515 0.698-3.290 0.293 
HR = hazard ratio; CB = confidence bounds. 
sis.3, 4, 15 However, if a prognostic system is to be of 
clinical relevance, it must also be reproducible. Un- 
fortunately, the assessment of the degree of peritu- 
moral lymphocytic infiltration has revealed poor in- 
traobserver and interobserver consistency in many of 
the compiled series. 9' 16 These results may be ex- 
plained by the variability in the lymphocytic infiltrate 
distribution in the different areas of the tumor 1< iv 
and the subjective nature of this parameter, given that 
it depends on the transforming of a visual interpreta- 
tion into categories by the pathologist. In our experi- 
ence, no significant difference in survival was found 
between patients with conspicuous infiltrate and 
those without it. These data were confirmed using 
Cox regression analysis. In fact, no independent prog- 
nostic value of this parameter was found in tumors of 
the colon and the rectum, which had been analyzed 
together. Similar findings have been found in colonic 
cancers by Shepherd et al. is and in colorectal lesions 
by Ponz de Leon et a I9  
Previous studies 9' 16, 17 demonstrated that the other 
subjective variable of the Jass system, i.e., the type of 
invasive margin, can be reliably assessed with high 
levels of intraobserver and interobserver agreement. 
Moreover, assessment is not significantly affected by 
the site of sampling of the invasive tumor margin. 16 In 
agreement with previous reports, 3'4, 18, 19 the present 
study shows that this parameter is a good prognostic 
factor and was selected for its independent value on 
survival by multivariate analysis. 
The other variable, which was found to be of inde- 
pendent prognostic significance, is the number of 
metastatic lymph nodes. On the other hand, the depth 
of local invasion did not provide any further prognos- 
tic information in our series. 
These findings suggested that a new prognostic 
model might be possible using the character of the 
invasive margin as a discriminating factor within 
lymph node-negative and lymph node-positive pa- 
tients. Among the first group, which included those 
subjects in Dukes A and B stages, our patients with 
pushing tumors had a 88.5 percent five-year survival 
rate. Thus, they should have been considered as hav- 
ing as good a prognosis as that of patients with Stage 
A or those who had been placed in Jass Group I. 
Instead, those patients with infiltrating tumors were 
still classified as having an indefinite clinical outcome, 
given that their five-year survival rate was 66.1 per- 
cent. With regard to those patients with positive 
lymph nodes and, in particular, those with one to four 
positive lymph nodes or Stage C1, the 100 percent 
five-year survival rate associated with pushing tumors 
was probably overrated given that the number of 
patients was small. However, it does represent both 
an unexpected and significant result hat has not been 
reported previously. In fact, only Fisher and cowork- 
ers 9 noted that patients with C1 lesions, who had Jass 
scores of I and 1I, exhibited survival patterns imilar to 
those patients lacking nodal metastases or Stage B 
patients. However, further confirmation with larger 
patient populations may be necessary. On the other 
hand, patients with Cl-infiltrating tumors and patients 
with more than four lymph nodes involved, that is, 
Stage C2 (all with infiltrating tumors), were consis- 
tently associated with a poor prognosis (28.7 and 0 
percent at 5 years, respectively). 
When subsets of our patients with good and poor 
prognoses were considered together, the new prog- 
nostic model, which can be easily used in clinical 
practice by the addition of the type of invasive margin 
to the Dukes classification, allowed for placement of 
59.6 percent of the patients into groups that provided 
more confident prognoses. The percentage of pa- 
tients was higher than when the Dukes and Jass clas- 
sifications (25.9 and 42.5 percent, respectively) were 
used. Unfortunately, patients classified as Dukes A 
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and B with infiltrating tumors still represent a prog- 
nostic group with unsatisfactory individual patient 
prediction. Further prognostic discrimination is nec- 
essary, and new biologic parameters, uch as DNA 
ploidy 2~ and cell kinetics, 21 will no doubt help in this 
direction. 
CONCLUSION 
The character of the invasive margin in colorectal 
cancer is a valid factor in predicting survival. More- 
over, the use of the combination of this parameter 
with the traditional Dukes classification may add use- 
ful prognostic information and may be of value in 
selecting patients who could receive the most benefit 
from adjuvant herapy. 
REFERENCES 
1. Dukes CE. The classification of cancer of the rectum. 
J Pathol Bacteriol 1932;35:323-32. 
2. Gabriel WB, Dukes C, Bussey HJ. Lymphatic spread in 
cancer of the rectum. Br J Surg 1935;23:395-413. 
3. Jass JR, Love S, Northover JM. A new prognostic classi- 
fication for rectal cancer. Lancet 1987;1:1303-6. 
4. Jass JR, Atkin WS, Cusick J, et al. The grading of rectal 
cancer: historical perspectives and a multivariate anal- 
ysis of 447 cases. Histopathology 1986;10:437-59. 
5. Kaplan E, Meier P. Non parametric estimation from 
incomplete observations. J Am Stat Assoc 1958;53: 
457-81. 
6. Cox DR. Regression model and life tables. J R Stat Soc 
(B) 1972;34:187-220. 
7. Gastrointestinal Tumor Study Group. Adjuvant herapy 
of colon cancer: results of a prospectively randomized 
trial. N Engl J Med 1984;310:737-43. 
8. Wolmark N, Fisher B, Wieand HS. The prognostic value 
of the modifications of the Dukes' C class of colorectal 
cancer: an analysis of the NSABP clinical trials. Ann Surg 
1986;203:115-22. 
9. Fisher ER, Robinsky B, Sass R, Fisher B, and other 
NSABP collaborators. Relative prognostic value of the 
Dukes and the Jass systems in rectal cancer: findings 
from the National Surgical Adjuvant Breast and Bowel 
Projects (Protocol R-01). Dis Colon Rectum 1989;32: 
944-9. 
10. Dukes CE, Bussey EIJ. The spread of rectal cancer and 
its effect on prognosis. BrJ Cancer 1958;12:309-20. 
11. Carlon CA, Fabris G, Arslan-Pagnini C, Pluchinotta AM, 
Chinelli F, Carniato S. Prognostic orrelations of oper- 
able carcinoma of the rectum. Dis Colon Rectum 1985; 
28:47-50. 
12. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey 
EL. Pathologic determinants of survival associated with 
colorectal cancer with lymph node metastases: a mul- 
tivariate analysis of 579 patients. Cancer 1994;73: 
2076-82. 
13. Deans GT, Parks TG, Rowlands BJ, Spence RA. Prog- 
nostic factors in colorectal cancer. Br J Surg 1992;79: 
608-13. 
14. Secco GB, Fardelli R, Campora E, etal .  Prognostic value 
of the Jass histopathologic classification in left colon 
and rectal cancer: a multivariate analysis. Digestion 
1990;47:71-80. 
15. Jass JR, Morson BC. Reporting colorectal cancer. J Clin 
Pathol 1987;40:1016--23. 
16. Dundas SA, Laing RW, O' Cathain A, et al. Feasibility of 
new prognostic lassification for rectal cancer. J Clin 
Pathol 1988;41:1273-6. 
17. Lanza G Jr, Borghi L, Ballotta MR, et al. Valutazione di 
parametri prognostici nel carcinoma de1 colon retto. I. 
Variabili istopatologiche. Pathologica 1992;84:131-53. 
18. Shepherd NA, Saraga E-P, Love SB, Jass JR. Prognostic 
factors in colonic cancer. Histopathology 1989;14: 
613-30. 
19. Ponz de Leon M, Sant M, Micheli A, et al. Clinical and 
pathologic prognostic indicators in colorectal cancer: a 
population-based study. Cancer 1992;69:626-35. 
20. Chapman MA, Hardcastle JD, Armitage NC. Five-year 
prospective study of DNA tumor ploidy and colorectal 
cancer survival. Cancer 1995;76:383-7. 
21. Pietra N, Sarli L, Sansebastiano G,Jotti GS, Peracchia A. 
Prognostic value of ploidy, cell proliferation kinetics, 
and conventional c inicopathologic criteria in patients 
with colorectal carcinoma:  prospective study. Dis Co- 
lon Rectum 1996;39:494-503. 
Invited Editorial 
By linking the histologic nature of the tumor margin 
to a modification of Dukes staging, Dr. Cianchi and 
associates have been able to identify a greater per- 
centage of patients with either a good or poor prog- 
nosis than is possible using either a modification of 
Dukes staging or the Jass prognostic lassification. 
Interestingly, in their analysis of the "Jass" variables 
(direct spread and peritumoral lymphocytic infiltra- 
tion), the authors failed to demonstrate hat either had 
a significant independent prognostic effect. This may 
be explained by a difference in the method of data 
collection and/or by the fact that the series included 
both colonic and rectal cancers. The Jass system was 
developed specifically for rectal cancer. Subsequent 
work has shown that lymphocytic infiltration has no 
independent prognostic significance in colonic can- 
cer. The authors suggest hat difficulty in assessing 
this subjective variable may have been a factor in 
explaining the difference in their findings. 
When only pathology variables are considered, di- 
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rect spread is widely accepted as having an important 
independent prognostic effect. The reason for the 
failure to demonstrate such an effect in the present 
series is not readily apparent. For the above reasons, 
it would seem prudent o suggest hat further studies 
be undertaken on a larger series of patients before 
making recommendations on the use of the proposed 
system. 
In the writer's view, formulation of a new prognos- 
tic classification should ideally evolve from the results 
of a multivariate analysis on a comprehensive range 
of prognostic variables performed for each tumor 
stage. Tumor site should be included in the model, 
and if shown to have a significant independent effect, 
analysis hould be done separately for the colon and 
rectum. 
Ronald C. Newland, M.D. 
Sydney, Australia 
The Authors Reply 
Both the Dukes and Jass classifications were origi- 
nally developed for rectal cancer, ~' 2 but they are 
currently used by pathologists and surgeons even for 
prognostic evaluation of colonic cancer. Both of these 
systems howed a clear correlation with survival in 
our series. 
With regard to direct spread of tumor (classified as 
limited to the bowel wall or extending beyond it), we 
found that it significantly influenced survival at uni- 
variate analysis. Nevertheless, when all histopatho- 
logic parameters used in the two systems had been 
evaluated at multivariate analysis, we found that only 
the type of invasive margin and the number of met- 
astatic lymph nodes had any independent prognostic 
significance. The lack of prognostic value for direct 
spread at multivariate analysis may be explained by 
the valid effect of the type of invasive margin in 
predicting death as the result of either distant metas- 
tases or local recurrence. The direct spread of the 
tumor is likely to be related to only local recurrence, 
and thus, it shows a less meaningful prognostic sig- 
nificance. 
Even if peritumoral lymphocytic infiltration may 
have potential prognostic value for only rectal tumors, 
as Dr. Newland suggests, in our opinion, this variable 
cannot be reliably used by pathologists for prognostic 
evaluation regarding either colonic or rectal tumors. 
In fact, assessment of this parameter is not objectively 
reproducible, and the degree of its observer consis- 
tency, as reported in some studies, has been little 
better than that expected by pure chance. 3'4 
We agree with Dr. Newtand when he suggested 
that further studies be undertaken on a larger series of 
patients. This may be necessary to confirm our finding 
and obtain more detailed ata by considering colonic 
and rectal cancers eparately. 
In any case, we sought and finally proposed a 
prognostic model that can be reliably adopted for 
both colonic and rectal cancer by adding the type of 
invasive margin to Dukes staging. Thus, the clinical 
use of this prognostic model is very easy. Moreover, 
the most important finding from a clinical point of 
view is that this model can provide more prognostic 
information than either the Dukes or Jass classifica- 
tion. In fact, we have constructed a model that can 
identify a greater percentage of patients with either a 
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